Vistagen Therapeutics, Inc.
fasiedienol
social anxiety disorder
Resolved
7days ago
Phase 3 readout · ~ Jun 30, 2026 estimated
What's at stake
Phase 3 trial results for fasiedienol in social anxiety disorder are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“expects topline results from its PALISADE-4 Phase 3 trial in the first half of 2026”